Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA

Autor: Pj, Snijders, van Duin M, Jm, Walboomers, Renske Steenbergen, Ek, Risse, Tj, Helmerhorst, Rh, Verheijen, Cj, Meijer

Publikováno v: Europe PubMed Central

In this study, we investigated telomerase activity and human telomerase reverse transcriptase (hTERT) mRNA expression in relation to high-risk human papillomavirus (HPV) DNA presence in the spectrum of cervical premalignant lesions. Reconstruction ex

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::25dfbc41257efa8fd97502b731e6ce7f
http://europepmc.org/abstract/med/9731489

Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN.

Autor: Polman NJ; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Uijterwaal MH; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Witte BI; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands., Berkhof J; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands., van Kemenade FJ; Department of Pathology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Spruijt JW; Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, The Netherlands., van Baal WM; Department of Obstetrics and Gynecology, Flevo Hospital, Almere, The Netherlands., Graziosi PG; Department of Obstetrics and Gynecology, Sint Antonius Hospital, Nieuwegein, The Netherlands., van Dijken DK; Department of Obstetrics and Gynecology, Onze Lieve Vrouwen Gasthuis West, Amsterdam, The Netherlands., Verheijen RH; Department of Gynaecological Oncology, Division of Surgical Oncology, UMC Utrecht Cancer Center, Utrecht, The Netherlands., Helmerhorst TJ; Department of Obstetrics and Gynecology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Steenbergen RD; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Heideman DA; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Ridder R; Roche mtm Laboratories AG, Mannheim, Germany.; Ventana Medical Systems, Inc., Tucson, Arizona., Snijders PJ; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Meijer CJ; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.

Publikováno v: International journal of cancer [Int J Cancer] 2017 Jan 15; Vol. 140 (2), pp. 423-430. Date of Electronic Publication: 2016 Oct 11.

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women.

Autor: Luttmer R; Department of Pathology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., De Strooper LM; Department of Pathology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., Dijkstra MG; Department of Obstetrics and Gynaecology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., Berkhof J; Department of Epidemiology and Biostatistics, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., Snijders PJ; Department of Pathology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., Steenbergen RD; Department of Pathology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., van Kemenade FJ; Department of Pathology, Erasmus Medical Center, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands., Rozendaal L; Department of Pathology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., Helmerhorst TJ; Department of Obstetrics and Gynaecology, Erasmus MC University Medical Center, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands., Verheijen RH; UMC Utrecht Cancer Center, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands., Ter Harmsel WA; Roosevelt Clinic, Rooseveltstraat 67, 2321 CT Leiden, The Netherlands., van Baal WM; Department of Obstetrics and Gynaecology, Flevo Hospital, Hospitaalweg 1, 1315 RA Almere, The Netherlands., Graziosi PG; Department of Obstetrics and Gynaecology, Sint Antonius Hospital, Koekoekslaan 1, 3435 CM Nieuwegein, The Netherlands., Quint WG; DDL Diagnostic Laboratory, Visseringlaan 25, 2288 ER Rijswijk, The Netherlands., Spruijt JW; Department of Obstetrics and Gynaecology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., van Dijken DK; Department of Obstetrics and Gynaecology, Onze Lieve Vrouwe Gasthuis West, Oosterpark 9, 1091 AC Amsterdam, The Netherlands., Heideman DA; Department of Pathology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., Meijer CJ; Department of Pathology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

Publikováno v: British journal of cancer [Br J Cancer] 2016 Aug 23; Vol. 115 (5), pp. 579-87. Date of Electronic Publication: 2016 Jul 14.

Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).

Autor: Luttmer R; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., De Strooper LM; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Berkhof J; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands., Snijders PJ; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Dijkstra MG; Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, The Netherlands., Uijterwaal MH; Department of Obstetrics and Gynecology, Flevo Hospital, Almere, The Netherlands., Steenbergen RD; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., van Kemenade FJ; Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands., Rozendaal L; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Helmerhorst TJ; Department of Obstetrics and Gynecology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Verheijen RH; Department of Obstetrics and Gynecology, University Medical Center Utrecht, Utrecht, The Netherlands., Ter Harmsel WA; Department of Gynecology, Roosevelt Clinic, Leiden, The Netherlands., Van Baal WM; Department of Obstetrics and Gynecology, Flevo Hospital, Almere, The Netherlands., Graziosi PG; Department of Obstetrics and Gynecology, Sint Antonius Hospital, Nieuwegein, The Netherlands., Quint WG; DDL Diagnostic Laboratory, Rijswijk, The Netherlands., Heideman DA; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Meijer CJ; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.

Publikováno v: International journal of cancer [Int J Cancer] 2016 Feb 15; Vol. 138 (4), pp. 992-1002. Date of Electronic Publication: 2015 Sep 14.

Adenocarcinoma in situ of the uterine cervix--a systematic review.

Autor: Baalbergen A; Department of Obstetrics and Gynecology, Reinier de Graaf Hospital, Delft, the Netherlands; and †Department of Obstetrics and Gynecology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., Helmerhorst TJ

Publikováno v: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2014 Nov; Vol. 24 (9), pp. 1543-8.